Skip to main content
IRS-authorized e-file provider · not the IRS

Nonprofit · EIN 91-1828539

CANCER RESEARCH AND BIOSTATISTICS

Tax-exempt · SEATTLE, WA 98109

Financials

$12.1M$12.5M2023$11.3M$11.7M2024
Revenue Expenses · by fiscal year end
Financials of CANCER RESEARCH AND BIOSTATISTICS by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2024990$11,321,174$11,743,816-$422,642$9,891,691$4,484,508$5,407,183
December 31, 2023990$12,083,341$12,527,849-$444,508$11,524,760$5,790,827$5,733,933
Financial details: 990 for the year ended December 31, 2024

Revenue

Contributions, gifts and grants
$7,804,231
of which government grants
$7,804,231
Program service revenue
$3,474,029
Investment income
$42,045
Net gain from sales of assets
-$20,743
Other revenue
$869

Expenses

Grants and similar amounts paid
$0
Compensation of officers, directors and key employees
$1,130,657
Other salaries and wages
$5,832,483
Salaries, compensation and benefits (total)
$8,814,242
Professional fundraising fees
$0
Legal fees
$21,068
Accounting fees
$61,236
Occupancy
$1,166,065
Travel
$48,027
Depreciation
$221,573
Program services (functional)
$8,056,532
Management and general (functional)
$3,687,284

Balance sheet and other

Total assets, start of year
$11,524,760
Total assets, end of year
$9,891,691
Total liabilities, end of year
$4,484,508
Net assets, end of year
$5,407,183
Land, buildings and equipment
$706,036
Publicly traded securities
$2,208,630
Net assets without donor restrictions
$5,407,183
Gross receipts
$11,942,133
Employees
80
Volunteers
11
Year formed
1997
State of legal domicile
WA

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2024, highest compensation first.

NameTitleHours / weekCompensationOther / benefits
HOERING ANTJEPRESIDENT AND CEO
Trustee or director, Officer
40$425,309$39,058
MAR CHONG DAMIENCFO, TREASURER
Officer
40$215,062$24,301
COOK CHRISTOPHERCTO, SECRETARY
Officer
40$200,570$23,726
NISHIMURA KATHERINESR. BIOSTATISTICIAN
Highest-paid employee
40$180,571$21,842
DURHAM PATRICKDIRECTOR INFORMATION SECURITY
Highest-paid employee
40$167,758$21,963
GOREN EMILYSR. BIOSTATISTICIAN
Highest-paid employee
40$159,964$20,399
GODFREY TIMOTHYDIRECTOR APPLICATIONS DEVELOPMENT
Highest-paid employee
40$154,768$20,142
SUTTER RODNEYPROGRAM DIRECTOR THERAPEUTIC STUDIES
Highest-paid employee
40$149,119$19,640
MALLOY CURTISCOO, SECRETARY (UNTIL 4/12/24)
Officer
40$103,596$10,602
CROWLEY JOHNDIRECTOR, CHIEF OF STRATEGIC ALLIANCES
Trustee or director
16$88,433$0
ALVENDIA MELISSADIRECTOR
Trustee or director
1$0$0
CUMMINS TIMDIRECTOR
Trustee or director
1$0$0
CURCI FRANKDIRECTOR
Trustee or director
1$0$0
DAVIS RODERICDIRECTOR
Trustee or director
1$0$0
GRAY DAVIDDIRECTOR
Trustee or director
1$0$0
6 more people on this return
NameTitleHours / weekCompensation
GOODMAN GARYDIRECTOR
Trustee or director
1$0
HEAGHERTY PATRICKDIRECTOR
Trustee or director
1$0
LEBLANC MICHAELDIRECTOR
Trustee or director
1$0
ROSS ARTHURDIRECTOR
Trustee or director
1$0
SHAM JONATHANDIRECTOR
Trustee or director
1$0
SNAPINN STEVEDIRECTOR
Trustee or director
1$0
990 for the year ended December 31, 2023: 21 people
NameTitleHours / weekCompensationOther / benefits
HOERING ANTJECEO & BOARD PRESIDENT
Trustee or director, Officer
40$378,488$38,308
MALLOY CURTVP, COO & BOARD SECRETARY
Officer
40$221,445$28,014
COOK CHRISVP, CHIEF TECHNOLOGY OFFICER
Officer
40$198,488$23,618
MAR CHONG DAMIENVP, CFO & BOARD TREASURER
Officer
40$184,799$22,944
DURHAM PATRICK GDIRECTOR OF IT
Highest-paid employee
40$174,103$22,034
NISHIMURA KATHERINE KSENIOR BIOSTATISTICIAN
Highest-paid employee
40$172,007$21,152
MILLER BRIANDIRECTOR OF FINANCE
Highest-paid employee
40$166,668$17,995
BARLOW WILLIAM ESENIOR BIOSTATISTICIAN
Highest-paid employee
24$144,217$19,231
SUTTER RODNEYPROGRAM DIRECTOR, THERAPEUTIC STUDIES
Highest-paid employee
40$141,166$19,773
CROWLEY JOHN JDIRECTOR/CHIEF OF STRATEGIC ALLIANCES
Trustee or director
16$84,840$0
DAVIS RODERICDIRECTOR
Trustee or director
0$0$0
HEAGERTY PATRICKDIRECTOR
Trustee or director
0$0$0
CURCI FRANKDIRECTOR
Trustee or director
0$0$0
GOODMAN GARYDIRECTOR
Trustee or director
0$0$0
GRAY DAVIDDIRECTOR
Trustee or director
0$0$0
LEBLANC MICHAELDIRECTOR
Trustee or director
0$0$0
CUMMINS TIMDIRECTOR
Trustee or director
0$0$0
SNAPINN STEVEDIRECTOR
Trustee or director
0$0$0
ALVENDIA MELISSADIRECTOR
Trustee or director
0$0$0
ROSS ARTHURDIRECTOR
Trustee or director
0$0$0
SHAM JONATHANDIRECTOR
Trustee or director
0$0$0

Address and contacts

Address (IRS master file)
1505 WESTLAKE AVE N STE 750, SEATTLE, WA 98109-6244
In care of
% DAMIEN MAR CHONG
Principal officer (990 for 2024)
ANTJE HOERING, 1505 WESTLAKE AVENUE N 750, SEATTLE, WA 98109
Signed the 990
DAMIEN MAR CHONG, CFO
Phone
(206) 839-1710
Return prepared by
GREENWOOD OHLUND PS

Mission

TO HELP CONQUER CANCER AND OTHER DISEASES THROUGH THE APPLICATION OF BIOSTATISTICAL PRINCIPLES AND INNOVATIVE DATA MANAGEMENT METHODS.

990 for the year ended December 31, 2024

Program accomplishments

  • CANCER RESEARCH & BIOSTATISTICS (CRAB) IS A NATIONAL LEADER IN DESIGNING AND MANAGING ONCOLOGY CLINICAL TRIALS. CRAB IS THE STATISTICAL CENTER FOR SWOG (THE LARGEST NCI COOPERATIVE GROUP). IT IS CRAB'S GOAL TO PROVIDE SUPPORT AND STATISTICAL CONSULTATION FOR STUDY DESIGN, PROTOCOL DEVELOPMENT, RESEARCH DATA ANALYSIS, MANUSCRIPT WRITING, AND PRESENTATIONS AT MAJOR CONFERENCES IN ONCOLOGY RESEARCH. CRAB VALUES THE LONG-STANDING RELATIONSHIPS THAT IT HAS WITH ORGANIZATIONS TO WORK, SUPPORT AND DISCOVER NEW AND IMPROVED TREATMENTS FOR CANCER PATIENTS AND CONTINUES TO MAKE RESEARCH ALLIANCES WITH LEADING RESEARCH CONSORTIA, CANCER CENTERS, AND INDUSTRY. CRAB IS THE LEADER OF THE PANCREATIC CANCER RESEARCH TEAM (PCRT), A CONSORTIUM OF MORE THAN 40 CLINICS WORLDWIDE ESTABLISHED FOR BIOTECH AND PHARMACEUTICAL COMPANIES LOOKING TO DEVELOP NEW AGENTS FOR PATIENTS WITH PANCREAS CANCER.
    Expenses $8,040,048 · revenue $3,459,087
  • IN 2024, CRAB CONTINUED TO PROVIDE ONGOING SUPPORT THROUGH EXCELLENT TRAINING TO EARLY INVESTIGATORS AND CLINICAL RESEARCH ASSOCIATES.
    Expenses $16,484 · revenue $14,942

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026Not on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
91-1828539
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
1998
Accounting year ends
December
Files
Form 990 or 990-EZ
Category (NTEE)
Medical research (H30)
Assets (IRS master file)
$9,891,691
Income (IRS master file)
$11,942,133

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2024$11,321,174$11,743,816$9,891,691IRS
990December 2023$12,083,341$12,527,849$11,524,760XML
990December 2022$12,214,852$12,123,661$12,381,610IRS
990December 2021–––IRS
990December 2020–––IRS
990December 2018–––IRS
990December 2017–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 91-1828539).

Questions about CANCER RESEARCH AND BIOSTATISTICS

What is the EIN of CANCER RESEARCH AND BIOSTATISTICS?
The employer identification number (EIN) of CANCER RESEARCH AND BIOSTATISTICS is 91-1828539.
Is CANCER RESEARCH AND BIOSTATISTICS tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1998.
Are donations to CANCER RESEARCH AND BIOSTATISTICS tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does CANCER RESEARCH AND BIOSTATISTICS file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of CANCER RESEARCH AND BIOSTATISTICS due?
The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did CANCER RESEARCH AND BIOSTATISTICS last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2024.
Who is the principal officer of CANCER RESEARCH AND BIOSTATISTICS?
The 990 for the year ended December 31, 2024 names ANTJE HOERING.
Who are the officers and directors of CANCER RESEARCH AND BIOSTATISTICS?
The 990 for the year ended December 31, 2024 lists 21 people; 10 received compensation from the organization, the highest $425,309 (HOERING ANTJE, PRESIDENT AND CEO).
How much revenue does CANCER RESEARCH AND BIOSTATISTICS have?
On its 990 for the year ended December 31, 2024 it reported revenue of $11,321,174, expenses of $11,743,816 and total assets of $9,891,691 at year end.

Other nonprofits in SEATTLE

All nonprofits in SEATTLE · Washington · Medical research